231 related articles for article (PubMed ID: 32483203)
1. Novel biomarkers of a peripheral blood interferon signature associated with drug-naïve early arthritis patients distinguish persistent from self-limiting disease course.
Seyhan AA; Gregory B; Cribbs AP; Bhalara S; Li Y; Loreth C; Zhang Y; Guo Y; Lin LL; Feldmann M; Williams LM; Brennan FM; Taylor PC
Sci Rep; 2020 Jun; 10(1):8830. PubMed ID: 32483203
[TBL] [Abstract][Full Text] [Related]
2. Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis.
Yokoyama-Kokuryo W; Yamazaki H; Takeuchi T; Amano K; Kikuchi J; Kondo T; Nakamura S; Sakai R; Hirano F; Nanki T; Koike R; Harigai M
Arthritis Res Ther; 2020 Mar; 22(1):46. PubMed ID: 32164778
[TBL] [Abstract][Full Text] [Related]
3. Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsets.
Issa SF; Duer A; Østergaard M; Hørslev-Petersen K; Hetland ML; Hansen MS; Junker K; Lindegaard HM; Møller JM; Junker P
Arthritis Res Ther; 2017 Apr; 19(1):80. PubMed ID: 28446218
[TBL] [Abstract][Full Text] [Related]
4. The type I IFN signature as a biomarker of preclinical rheumatoid arthritis.
Lübbers J; Brink M; van de Stadt LA; Vosslamber S; Wesseling JG; van Schaardenburg D; Rantapää-Dahlqvist S; Verweij CL
Ann Rheum Dis; 2013 May; 72(5):776-80. PubMed ID: 23434571
[TBL] [Abstract][Full Text] [Related]
5. Circular RNAs Hsa_circ_0002715 and Hsa_circ_0035197 in Peripheral Blood Are Novel Potential Biomarkers for New-Onset Rheumatoid Arthritis.
Luo Q; Liu J; Fu B; Zhang L; Guo Y; Huang Z; Li J
Dis Markers; 2019; 2019():2073139. PubMed ID: 31772684
[TBL] [Abstract][Full Text] [Related]
6. IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Rodríguez-Carrio J; López P; Alperi-López M; Caminal-Montero L; Ballina-García FJ; Suárez A
Front Immunol; 2018; 9():3085. PubMed ID: 30666255
[No Abstract] [Full Text] [Related]
7. Aberrant dysregulated circular RNAs in the peripheral blood mononuclear cells of patients with rheumatoid arthritis revealed by RNA sequencing: novel diagnostic markers for RA.
Yang X; Li J; Wu Y; Ni B; Zhang B
Scand J Clin Lab Invest; 2019 Dec; 79(8):551-559. PubMed ID: 31596149
[TBL] [Abstract][Full Text] [Related]
8. circPTPN22 as a novel biomarker and ceRNA in peripheral blood mononuclear cells of rheumatoid arthritis.
Jiang Z; Zhong Z; Miao Q; Zhang Y; Ni B; Zhang M; Tang J
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184082
[TBL] [Abstract][Full Text] [Related]
9. Increased baseline RUNX2, caspase 3 and p21 gene expressions in the peripheral blood of disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients are associated with improved clinical response to methotrexate therapy.
Tchetina EV; Demidova NV; Markova GA; Taskina EA; Glukhova SI; Karateev DE
Int J Rheum Dis; 2017 Oct; 20(10):1468-1480. PubMed ID: 28741869
[TBL] [Abstract][Full Text] [Related]
10. Microarray Expression Profile of Circular RNAs in Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients.
Ouyang Q; Wu J; Jiang Z; Zhao J; Wang R; Lou A; Zhu D; Shi GP; Yang M
Cell Physiol Biochem; 2017; 42(2):651-659. PubMed ID: 28618429
[TBL] [Abstract][Full Text] [Related]
11. A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease.
Pratt AG; Swan DC; Richardson S; Wilson G; Hilkens CM; Young DA; Isaacs JD
Ann Rheum Dis; 2012 Aug; 71(8):1374-81. PubMed ID: 22532634
[TBL] [Abstract][Full Text] [Related]
12. Circular RNAs hsa-circ0000175 and hsa-circ0044235 in plasma are novel biomarkers for new-onset rheumatoid arthritis.
Gao Y; Yao F; Rao J; Zhang L; Guo Y; Huang Z; Huang Q; Li J; Luo Q
Autoimmunity; 2021 Jun; 54(4):234-242. PubMed ID: 34008433
[TBL] [Abstract][Full Text] [Related]
13. The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients.
Raterman HG; Vosslamber S; de Ridder S; Nurmohamed MT; Lems WF; Boers M; van de Wiel M; Dijkmans BA; Verweij CL; Voskuyl AE
Arthritis Res Ther; 2012 Apr; 14(2):R95. PubMed ID: 22540992
[TBL] [Abstract][Full Text] [Related]
14. Disease Characteristics and Rheumatoid Arthritis Development in Patients with Early Undifferentiated Arthritis: A 2-year Followup Study.
Brinkmann GH; Norli ES; Kvien TK; Haugen AJ; Grøvle L; Nygaard H; Bjørneboe O; Thunem C; Mjaavatten MD; Lie E
J Rheumatol; 2017 Feb; 44(2):154-161. PubMed ID: 28089976
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional signature associated with early rheumatoid arthritis and healthy individuals at high risk to develop the disease.
Macías-Segura N; Castañeda-Delgado JE; Bastian Y; Santiago-Algarra D; Castillo-Ortiz JD; Alemán-Navarro AL; Jaime-Sánchez E; Gomez-Moreno M; Saucedo-Toral CA; Lara-Ramírez EE; Zapata-Zuñiga M; Enciso-Moreno L; González-Amaro R; Ramos-Remus C; Enciso-Moreno JA
PLoS One; 2018; 13(3):e0194205. PubMed ID: 29584756
[TBL] [Abstract][Full Text] [Related]
16. Plasma interleukin-38 in patients with rheumatoid arthritis.
Xu WD; Su LC; He CS; Huang AF
Int Immunopharmacol; 2018 Dec; 65():1-7. PubMed ID: 30268016
[TBL] [Abstract][Full Text] [Related]
17. Reappraisal of the diagnostic and prognostic value of morning stiffness in arthralgia and early arthritis: results from the Groningen EARC, Leiden EARC, ESPOIR, Leiden EAC and REACH.
van Nies JA; Alves C; Radix-Bloemen AL; Gaujoux-Viala C; Huizinga TW; Hazes JM; Brouwer E; Fautrel B; van der Helm-van Mil AH
Arthritis Res Ther; 2015 Apr; 17(1):108. PubMed ID: 25904188
[TBL] [Abstract][Full Text] [Related]
18. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
[TBL] [Abstract][Full Text] [Related]
19. Prediction of therapeutic responses to tocilizumab in patients with rheumatoid arthritis: biomarkers identified by analysis of gene expression in peripheral blood mononuclear cells using genome-wide DNA microarray.
Sanayama Y; Ikeda K; Saito Y; Kagami S; Yamagata M; Furuta S; Kashiwakuma D; Iwamoto I; Umibe T; Nawata Y; Matsumura R; Sugiyama T; Sueishi M; Hiraguri M; Nonaka K; Ohara O; Nakajima H
Arthritis Rheumatol; 2014 Jun; 66(6):1421-31. PubMed ID: 24591094
[TBL] [Abstract][Full Text] [Related]
20. Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis.
Rannio T; Asikainen J; Kokko A; Hannonen P; Sokka T
J Rheumatol; 2016 Apr; 43(4):699-706. PubMed ID: 26879355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
